Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins*
AUTOR(ES)
Hamberg, Mats
RESUMO
Methods were developed for quantitative determination of the three major metabolites of arachidonic acid in human platelets, i.e., 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE), 12L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and 8-(1-hydroxy-3-oxopropyl)-9,12L-dihydroxy-5,10-heptadecadienoic acid (PHD). Aggregation of washed platelets by thrombin was accompanied by release of 1163-2175 ng/ml of HETE, 1129-2430 ng/ml of HHT, and 998-2299 ng/ml of PHD. The amount of PGG2 (prostaglandin G2) produced as calculated from the sum of the amounts of its metabolites (HHT and PHD) was 2477-5480 ng/ml. In contrast, the amounts of PGE2 (prostaglandin E2) and PGF2α (prostaglandin F2α) released were approximately two orders of magnitude lower. In this system, the prostaglandins thus exert their biological action through the endoperoxides, which are almost exclusively metabolized to nonprostanoate structures and only to a small extent to the classical prostaglandins.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=434276Documentos Relacionados
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
- Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets*
- Synthesis and biological properties of a 9,11-azo-prostanoid: highly active biochemical mimic of prostaglandin endoperoxides.
- Molecular cloning and spatio-temporal expression of the prostaglandin transporter: A basis for the action of prostaglandins in the bovine reproductive system
- Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.